Article Text

Clomipramine withdrawal in newborns
  1. B R BLOEM,
  2. G J LAMMERS
  1. Department of Neurology
  2. Leiden University Medical Centre
  3. PO Box 9600
  4. 2300 RC Leiden
  5. The Netherlands
  6. Email: bloem@rullf2.medfac.leidenuniv.nl
  7. Department of Paediatrics
  8. Department of Paediatric Neurology
    1. D W E ROOFTHOOFT,
    2. A J DE BEAUFORT
    1. Department of Neurology
    2. Leiden University Medical Centre
    3. PO Box 9600
    4. 2300 RC Leiden
    5. The Netherlands
    6. Email: bloem@rullf2.medfac.leidenuniv.nl
    7. Department of Paediatrics
    8. Department of Paediatric Neurology
      1. O F BROUWER
      1. Department of Neurology
      2. Leiden University Medical Centre
      3. PO Box 9600
      4. 2300 RC Leiden
      5. The Netherlands
      6. Email: bloem@rullf2.medfac.leidenuniv.nl
      7. Department of Paediatrics
      8. Department of Paediatric Neurology

        Statistics from Altmetric.com

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        Editor—Maternal clomipramine use during pregnancy may cause epilepsy in newborns.1-3 We present the case of a neonate who developed a thus far unrecognised manifestation of clomipramine withdrawal.

        A 38 year old woman had been treated for depression throughout pregnancy with clomipramine (100 mg/day). No other medication had been taken. A boy weighing 3370 g was born at term; he had excellent Apgar scores. Two days later, the child was jittery following startling impulses. On the fifth day, simultaneous …

        View Full Text